CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Clindamycin Phosphate In Dextrose 5%, and when can generic versions of Clindamycin Phosphate In Dextrose 5% launch?
Clindamycin Phosphate In Dextrose 5% is a drug marketed by Abraxis Pharm, Hikma, Abbott Labs, and Baxter Hlthcare. and is included in five NDAs.
The generic ingredient in CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clindamycin Phosphate In Dextrose 5%
A generic version of CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% was approved as clindamycin phosphate by ALMAJECT on July 24th, 1987.
Summary for CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 33 |
| Clinical Trials: | 30 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% at DailyMed |
Recent Clinical Trials for CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Daré Bioscience, Inc. | Phase 1 |
| Memorial Sloan Kettering Cancer Center | Phase 2 |
| Daré Bioscience, Inc. | Phase 3 |
See all CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% clinical trials
Pharmacology for CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
| Drug Class | Lincosamide Antibacterial |
| Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Anatomical Therapeutic Chemical (ATC) Classes for CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
US Patents and Regulatory Information for CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abraxis Pharm | CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% | clindamycin phosphate | INJECTABLE;INJECTION | 050636-001 | Dec 22, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Abbott Labs | CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER | clindamycin phosphate | INJECTABLE;INJECTION | 065027-002 | Jun 29, 2001 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Hikma | CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% | clindamycin phosphate | INJECTABLE;INJECTION | 214401-002 | Apr 5, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
